Acme United Q2 2026 Earnings Beat on MyMedic Acquisition and Margin Recovery

• Acme United reported second-quarter 2026 earnings per share of $1.22, significantly surpassing the consensus estimate of $0.81 and marking a substantial beat for investors.
• Revenue climbed 16% year-over-year to $62.7 million, driven largely by the strategic acquisition of MyMedic and robust organic growth across segments.
• The company's consolidated gross margin expanded to 42.6%, reflecting a successful transition to lower-cost inventory that is mitigating recent tariff-induced headwinds.
• Despite the positive financial outperformance, investors are closely monitoring elevated selling, general, and administrative expenses that remain at 32% of sales, potentially pressuring net profitability.

Acme United Corporation delivered a robust performance in the second quarter of 2026, significantly outperforming market expectations across key financial metrics. The company reported earnings per share of $1.22, which exceeded the consensus forecast by a wide margin. Revenue reached $62.72 million, beating the analyst estimate of $58.08 million and representing a 16.15% increase from the prior year period . This growth trajectory underscores the company's ability to leverage strategic acquisitions and capitalize on favorable market conditions to drive top-line expansion.

The primary catalyst for this financial outperformance was the acquisition of MyMedic, a move that has significantly altered the company's product mix and revenue composition. The acquisition, which was completed in January 2026, contributed approximately $4.3 million in sales during the second quarter alone . Excluding the impact of this acquisition, the company still achieved an organic growth rate of 8%, indicating strong underlying demand for its existing product portfolio . The MyMedic brand, known for its first aid and safety products, has been integrated into Acme United's broader distribution network, with management noting particular strength in European markets where net sales grew 19% in local currency .

How Is Acme United Managing Tariff Pressures?

Margin expansion has been a central theme of Acme United's recent operational strategy, with gross margins improving to 42.6% from 41.0% in the prior year period . This 160 basis point improvement is largely attributed to a favorable shift in product mix toward higher-margin MyMedic products . Management has also implemented strategic inventory transitions to address the impact of trade tariffs, which had previously compressed U.S. margins by approximately 100 basis points earlier in the year . By allowing lower-cost inventory to replace higher-tariff stock, the company is actively mitigating cost pressures and signaling a medium-term recovery in profitability .

CEO Johnsen highlighted that these tariff-related cost pressures are expected to ease as the inventory transition progresses throughout the remainder of the year . This strategic move is designed to stabilize margins and support the company's broader profitability goals. The company's ability to navigate these macroeconomic headwinds demonstrates its operational resilience and adaptability in a complex trade environment.

What Are the Key Risks for Investors?

Despite the strong quarterly results, several risks warrant close attention from investors. Selling, general, and administrative expenses remain elevated at 32% of sales, which could constrain net income growth if not managed effectively . The integration of MyMedic has also contributed to these higher expenses due to initial advertising costs and operational setup, although management expects profitability to improve with particular strength in the fourth quarter . Seasonal demand patterns typically drive roughly 35% of annual sales in Q4, which could provide a significant boost to the bottom line .

Geographic performance has been uneven, with Canada currently lagging behind other regions such as the U.S. and Europe . The U.S. segment, excluding the impact of MyMedic, saw a 17% increase in net sales, while the Westcott brand showed signs of recovery with an 8% increase in cutting tools sales . Additionally, Spill Magic reported approximately 30% year-to-date growth, supported by new automation and the establishment of a permanent facility in Tennessee . Investors should also monitor potential volatility in freight costs and currency fluctuations, which could impact future financial performance . The company generated approximately $15 million in free cash flow, providing flexibility for strategic investments and debt management .

The stock market reacted positively to the earnings report, with shares surging nearly 12% to approach a 52-week high of $51.88 . This positive market response reflects investor confidence in the company's growth trajectory and margin expansion strategy. However, the elevated SG&A expenses and uneven geographic performance remain key variables that could influence future stock valuation and investor sentiment.

Acme United's second-quarter results highlight the company's ability to drive growth through strategic acquisitions and operational efficiency. The successful integration of MyMedic and the mitigation of tariff pressures have positioned the company for continued margin expansion. As the company navigates near-term risks and capitalizes on seasonal demand, its performance will be closely watched by investors seeking exposure to diversified industrial manufacturers with strong growth potential.

The focus on expanding MyMedic distribution beyond direct-to-consumer channels into mass retail represents a significant growth opportunity for the company . This strategic initiative, combined with the ongoing inventory transition, is expected to drive sustained profitability improvements in the coming quarters. Investors should remain attentive to the company's execution on these strategic priorities and its ability to manage cost structures effectively.